Clinical trial

Safety Study of BMS-823778 in Subjects With Type 2 Diabetes

NCT01111955

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2010-07-01

PhasePHASE2

Study timeline

Study start (unknown)2010-07-01Date precision: month

Registry last updated2015-10-12

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Diabetes Mellitus, Type 2unresolved

Interventions

BMS-823778DRUG

PlaceboDRUG

MetforminDRUG · verified · RxNorm: metformin

Sponsors & collaborators

Bristol-Myers Squibblead sponsor

Mapped research locations

MilwaukeeWisconsin, United States1 QuébecQuebec, Canada1 WinnipegManitoba, Canada1 HialeahFlorida, United States1 SaskatoonSaskatchewan, Canada1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01111955 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.